PPP2R1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.10862446895044E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.04269926026745E-11 |
Normal-vs-Stage2 |
6.18789999999869E-05 |
Normal-vs-Stage3 |
1.11022302462516E-16 |
Normal-vs-Stage4 |
1.49199541610301E-11 |
Stage1-vs-Stage2 |
7.991200E-01 |
Stage1-vs-Stage3 |
1.440740E-04 |
Stage1-vs-Stage4 |
1.712030E-02 |
Stage2-vs-Stage3 |
2.151900E-02 |
Stage2-vs-Stage4 |
8.256500E-02 |
Stage3-vs-Stage4 |
6.650200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62658775337832E-12 |
Normal-vs-AfricanAmerican |
7.28229999635843E-08 |
Normal-vs-Asian |
1.515660E-03 |
Caucasian-vs-AfricanAmerican |
5.837800E-01 |
Caucasian-vs-Asian |
9.993000E-01 |
AfricanAmerican-vs-Asian |
8.296600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
9.68890001562528E-09 |
Male-vs-Female |
1.185700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.20259996089823E-09 |
Normal-vs-Age(41-60Yrs) |
3.28637117519293E-12 |
Normal-vs-Age(61-80Yrs) |
1.62581059726108E-12 |
Normal-vs-Age(81-100Yrs) |
1.001930E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.745970E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.769600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.520600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.152370E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.279200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.784200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.477000E-01 |
Normal-vs-Grade 2 |
1.77129977352308E-10 |
Normal-vs-Grade 3 |
1.62458935193399E-12 |
Normal-vs-Grade 4 |
1.62625468647093E-12 |
Grade 1-vs-Grade 2 |
2.789600E-02 |
Grade 1-vs-Grade 3 |
1.960520E-03 |
Grade 1-vs-Grade 4 |
2.780800E-04 |
Grade 2-vs-Grade 3 |
4.059700E-03 |
Grade 2-vs-Grade 4 |
9.389300E-04 |
Grade 3-vs-Grade 4 |
2.548800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.94679999898639E-08 |
Normal-vs-ccB subtype |
1.62470037423645E-12 |
ccA subtype-vs-ccB subtype |
2.41729999999052E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62825308791525E-12 |
Normal-vs-N1 |
1.54475999999404E-05 |
N0-vs-N1 |
7.491400E-01 |
|
|